Single domain antibody for programmed death-ligand (pd-l1) and derived protein thereof

• 收藏
• 分享

专利权人:

Jiangsu Alphamab Biopharmaceuticals Co. Ltd.;3D Medicines (Beijing) Co. Ltd

发明人:

Xu, Ting,Dong, Yanrong,Wang, Pilin,Chen, Ting

申请号：

NZ73949916

公开号：

NZ739499A

申请日:

2016.08.01

申请国别(地区):

NZ

年份:

2019

代理人:

摘要：

The present invention relates to the biomedical field, and provides a single domain antibody for programmed death-ligand (PD-L1) and a derived protein thereof. The present invention also provides a use of a PD-L1 binding molecule in treating and/or preventing and diagnosing a PD-L1 related disease, such as tumor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/